CNN —

The U.S. Food and Drug Administration approved updated COVID-19 vaccines but for a more limited group: adults age 65 and older and younger people who are at higher risk from COVID-19.

"FDA has now issued marketing authorization for those at higher risk: Moderna (6+ months), Pfizer (5+), and Novavax (12+). These vaccines are available for all patients who choose them after consulting with their doctors," US Health and Human Services Secretary Robert F. Kennedy Jr. said in a post on X .

Kennedy said in this post that he had promised "to keep vaccines available to people who want them, especially the vulnerable," but the move may limit access to COVID-19 shots for people who were routinely able to get them in the past.

It may be significantly more difficult for infants and young c

See Full Page